These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 2415203

  • 1. Cisplatin combination chemotherapy for advanced germ-cell testicular tumours.
    Taylor RE, Duncan W, Davey P, Munro AJ, Cornbleet MA.
    Br J Urol; 1985 Oct; 57(5):567-73. PubMed ID: 2415203
    [Abstract] [Full Text] [Related]

  • 2. Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours.
    Horwich A, Brada M, Nicholls J, Jay G, Hendry WF, Dearnaley D, Peckham MJ.
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):177-84. PubMed ID: 2467806
    [Abstract] [Full Text] [Related]

  • 3. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
    Fizazi K, Pagliaro L, Laplanche A, Fléchon A, Mardiak J, Geoffrois L, Kerbrat P, Chevreau C, Delva R, Rolland F, Theodore C, Roubaud G, Gravis G, Eymard JC, Malhaire JP, Linassier C, Habibian M, Martin AL, Journeau F, Reckova M, Logothetis C, Culine S.
    Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
    [Abstract] [Full Text] [Related]

  • 4. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
    Pizzocaro G, Salvioni R, Pasi M, Zanoni F, Milani A, Pilotti S, Monfardini S.
    Cancer; 1985 Jul 15; 56(2):249-55. PubMed ID: 2408728
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High-dose versus low-dose vinblastine in cisplatin-vinblastine-bleomycin combination chemotherapy of non-seminomatous testicular cancer: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group.
    Stoter G, Sleyfer DT, ten Bokkel Huinink WW, Kaye SB, Jones WG, van Oosterom AT, Vendrik CP, Spaander P, de Pauw M, Sylvester R.
    J Clin Oncol; 1986 Aug 15; 4(8):1199-206. PubMed ID: 2426419
    [Abstract] [Full Text] [Related]

  • 11. [BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors].
    Mori Y, Shima H, Ihara H, Yabumoto H, Iwasaki A, Yoshioka M, Ikoma F.
    Hinyokika Kiyo; 1992 Oct 15; 38(10):1139-42. PubMed ID: 1282774
    [Abstract] [Full Text] [Related]

  • 12. Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients.
    Soulié P, Garrino C, Bensmaïne MA, Bekradda M, Brain E, Di Palma M, Goupil A, Misset JL, Cvitkovic E.
    J Cancer Res Clin Oncol; 1999 Dec 15; 125(12):707-11. PubMed ID: 10592105
    [Abstract] [Full Text] [Related]

  • 13. Prognostic factors for favorable outcome in disseminated germ cell tumors.
    Birch R, Williams S, Cone A, Einhorn L, Roark P, Turner S, Greco FA.
    J Clin Oncol; 1986 Mar 15; 4(3):400-7. PubMed ID: 2419524
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary. An EORTC Gynaecological Cancer Cooperative Group study.
    Pecorelli S, Wagenaar HC, Vergote IB, Curran D, Beex LV, Wiltshaw E, Vermorken JB.
    Eur J Cancer; 1999 Sep 15; 35(9):1331-7. PubMed ID: 10658523
    [Abstract] [Full Text] [Related]

  • 20. Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up.
    Dearnaley DP, Horwich A, A'Hern R, Nicholls J, Jay G, Hendry WF, Peckham MJ.
    Eur J Cancer; 1991 Sep 15; 27(6):684-91. PubMed ID: 1712606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.